Pharmaceutical and biotech companies compete in a complex and high-risk marketplace. Success often depends on the right strategy, and increasingly on the right partnerships.
Early-stage and mid-size pharmaceutical and biotech companies typically depend on licensing and partnerships as an effective path to revenue and market success, especially in times of industry change and risk-adverse investors. Companies must first identify the best potential partners to approach for the product under development. Then, the most effective out-licensing efforts require the input of business development professionals with both commercialization and deal experience, plus a wide network of personal relationships and industry contacts. TCG immediately brings these critical factors to your team.
In addition to partnering support, TCG provides sales and market development expertise to small and mid-sized pharmaceutical companies, to help enhance the performance of currently marketed products, or to assess new indications or markets. TCG consultants have created the most effective marketing and sales strategies and then helped to implement them.
To see Case Studies on TCG’s successful track record of assisting small to mid-sized biotech/pharmaceutical companies, see below:
- Unlocking Early Value in a Development Stage Therapeutics Company
- Creative Financing for Product Development for an Early Stage Biotech Company
- Creative R&D Partnering Options for an Early Stage Biotech Company
- Opportunity Assessment for an M & A Project
- Assessing the Market Potential for a Novel Active Ingredient
- Accelerating Time-to-Market in an Early Stage Company Through Licensing
“Deal experience plus a wide network of personal contacts“
